SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-00-000292
Filing Date
2000-06-29
Accepted
2000-06-29 00:00:00
Documents
1
Group Members
E.M. WARBURG, PINCUS & CO., LLCWARBURG PINCUS EQUITY PARTNERS LPWARBURG, PINCUS & CO.WARBURG, PINCUS EQUITY PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D 0001.txt SC 13D/A 34329
  Complete submission text file 0000899140-00-000292.txt   36415
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-47221 | Film No.: 664971
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 466 LEXINGTON AVE. NEW YORK NY 10017 2128780600
WARBURG PINCUS EQUITY PARTNERS LP (Filed by) CIK: 0001075598 (see all company filings)